Haemonetics Corp sells products used to process, handle, and analyze blood. The firm sells products in four categories: Plasma, Hemostasis Management, Blood Center and Cell Processing. The Plasma business includes plasma collection devices and disposables. Hemostasis Management includes devices and methodologies for measuring coagulation characteristics of blood, Blood Center includes blood collection and processing devices and disposables for red cells and Cell Processing include surgical blood salvage systems, specialized blood cell processing systems, disposables and blood transfusion management software.
| Website: | www.haemonetics.com |
| Email: | gerry.gould@haemonetics.com |
| Main Phone: | +1 781 848-7100 |
| Address: | 400 Wood Road |
| Address 2: | Suite 2100 |
| State: | MA |
| City / Town: | Braintree |
| Country: | USA |
| Postal Code: | 02184-9114 |
| Exchange: | NYE |
| CEO: | Christopher Simon |
| Employees: | 3136 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
Gathering Data... Please wait Haemonetics Corp sells products used to process, handle, and analyze blood. The firm sells products in four categories: Plasma, Hemostasis Management, Blood Center and Cell Processing. The Plasma business includes plasma collection devices and disposables. Hemostasis Management includes devices and methodologies for measuring coagulation characteristics of blood, Blood Center includes blood collection and processing devices and disposables for red cells and Cell Processing include surgical blood salvage systems, specialized blood cell processing systems, disposables and blood transfusion management software.
| Website: | www.haemonetics.com |
| Email: | gerry.gould@haemonetics.com |
| Main Phone: | +1 781 848-7100 |
| Address: | 400 Wood Road |
| Address 2: | Suite 2100 |
| State: | MA |
| City / Town: | Braintree |
| Country: | USA |
| Postal Code: | 02184-9114 |
| Exchange: | NYE |
| CEO: | Christopher Simon |
| Employees: | 3136 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
| Last Price 100.92 | Change $ 1.35 | Change % 1.36 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 100.62 | High 102.28 | Low 100.12 | Prev Close 99.57 |
| Last Trade | Volume 440,436 | 52 Wk Hi 117.56 | 52 Wk Low 60.51 |
| Market Cap 5.2 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 51,684,326.00 | EPS (TTM) 0.40 | PE Ratio 252.30 | Exchange NYSE |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 12 | 133 |
| Number of Buys | 2 | 22 |
| Number of Sells | 10 | 111 |
| Net Activity | -4089 | 28088 |
| Last 10 Buys | Shares |
|---|---|
| Christopher Simon | 1,000 |
| Peter M. Allen | 1,000 |
| Dave Helsel | 1,000 |
| Jonathan White | 1,000 |
| Sandra L. Jesse | 1,000 |
| Christopher J. Lindop | 1,000 |
| Joseph J. Forish | 1,000 |
| Susan M. Hanlon | 1,000 |
| Peter M. Allen | 1,000 |
| Susan M. Hanlon | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Dan Goldstein | 1,000 |
| Christopher Simon | 1,000 |
| Dan Goldstein | 1,000 |
| Michelle L. Basil | 1,000 |
| Jacqueline Scanlan | 1,000 |
| William P. Burke | 1,000 |
| Neil Ryding | 1,000 |
| Dan Goldstein | 1,000 |
| Dan Goldstein | 1,000 |
| Dan Goldstein | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 100 | 100 | 100 | 100 |
| Low Target Price Estimate | 90 | 90 | 90 | 90 |
| Mean Target Price Estimate | 95 | 95 | 95 | 95 |
| Standard Deviation | 5 | 5 | 5 | 5 |
| Date of Most Recent Estimate | 05/11/18 | 05/11/18 | 05/11/18 | 06/07/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-06-14 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-12 |
| DEFA14A | Additional proxy soliciting materials - definitive | 2 | 2018-06-12 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 61 | 2018-06-12 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.86 | 1.86 | 1.86 | 1.86 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
